BIO compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name

BIOBio-Rad Laboratories, Inc.

Mkt capRevenueRevenue

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

Compare

BIOBio-Rad Laboratories, Inc.

AAgilent Technologies, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BIO1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+4.50%—

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+1.68%×0.22

Q2 FY26±7.7%▲+16.87%×2.19

= impliedBIO realized, solidA realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.4%

▼−3.01%

×0.47

Nov 25 '25±6.5%▲+2.34%×0.35

BIOBio-Rad Laboratories, Inc.

372.18▼−3.18%· post 372.18

Mkt cap$10.0BRevenue$651MQ2 FY26Revenue$2.6BFY25

AAgilent Technologies, Inc.

175.39▼−3.18%· post 173.02

ClosedOct 30 '26

Mkt cap$49.3BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

Compare

ClosedOct 30 '26

BIOBio-Rad Laboratories, Inc.

AAgilent Technologies, Inc.

372.18▼−3.18%post 372.18

Price

175.39▼−3.18%post 173.02

$10.0B

Mkt cap

$49.3B

Q2 FY26$651M

Revenue

$1.9BQ3 FY26

FY25$2.6B

Revenue

$6.9BFY25

BIO372.18▼−3.18%vsA175.39▼−3.18%ClosedOct 30 '26